Safety and Efficacy Study of NGGT003 in Hemophilia A Patients

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Hemophilia A

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Lei Zhang, MD) · zhanglei1@ihcams.ac.cn · +862223909240

Study leads

Lei Zhang, MD
Principal Investigator
Institute of Hematology & Blood Diseases Hospital, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Lentiviral FVIII Gene Therapy

Hemophilia A

Abroad (travel likely)RecruitingPHASE1

Shenzhen, China

A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

Severe Hemophilia A

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States · Greenville, United States

Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study

Hemophilia · Hemorrhage · Facelift Surgery

Abroad (travel likely)RecruitingEARLY_PHASE1

Minneapolis, United States

A Study of FVIII Gene Therapy for Hemophilia A

Hemophilia A

Abroad (travel likely)RecruitingEARLY_PHASE1

Tianjin, China